Chair: Siegfried Kasper, Medical University of Vienna, Austria and Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
Speaker: John H. Krystal, Yale School of Medicine, USA
Keynote Lecture
Where
Olympia Hall
10:00 - 10:30
Coffee Break
10:00 - 10:15
Showcase Presentation by Sage: How do you approach the treatment of depressive episodes today? What pathways are thought to play a role in depression?
Speaker: Professor Celso Arango
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañon
Ibiza 43, 28009 Madrid, Spain
Where
Olympia Foyer
10:30 - 12:00
Symposium: Breakthroughs and controversies in mood disorders
Chair: Georgia Salanti, Universität Bern, Switzerland and Ioannis Michopoulos, National and Kapodistrian University of Athens, Greece
Speaker: Alan Frazer, UT Health San Antonio, USA
Meet the Expert
Where
Attica Hall
12:00 - 13:00
Lunch / Poster Viewing
13:00 - 14:30
Workshop: Neurobiological and clinical characterization approaches for developing novel therapeutics for treatment-resistant depression
By Jennifer Evans National Institute of Mental Health, USA, Zhi-De Deng National Institute of Mental Health, USA, Carlos Zarate National Institute of Mental Health, USA, Christoph Kraus National Institute of Mental Health, USA, Bashkim Kadriu National Institute of Mental Health, USA
Chairs: Alan Frazer, UT Health San Antonio, USA and Thanasios Douzenis, National and Kapodistrian University of Athens, Greece
13:00-13:15: Towards clinical applications of fMRI - replicating global brain connectivity in treatment resistant depression. Christoph Kraus, National Institute of Mental Health, USA
13:20-13:35 Developing imaging markers of depression and treatment response. Jennifer Evans, National Institute of Mental Health, USA
13.40-13:55 Identification of neuroinflammatory markers via metabolomic profiling of a ketamine or placebo crossover trial in patients with treatment-resistant mood disorders. Bashkim Kadriu, National Institute of Mental Health, USA
14:00-14:15 Development of next generation seizure therapy for treatment resistant depression. Zhi-De Deng, National Institute of Mental Health, USA
14:20-14:30 Synopsis and outlook in developments. Discussant: Carlos Zarate, National Institute of Mental Health, USA
Satellite Symposium
Where
Templar's Hall
13:00 - 14:30
Symposium: Breakthroughs and controversies in psychosis
Chair: Carol Tamminga, UT Southwestern, USA and Nikos Stefanis, National and Kapodistrian University of Athens, Greece
13:00-13:25: New antipsychotic drugs. Dr. Carol Tamminga, UT Southwestern, USA
13:30-13:55: Controversies in literature in antipsychotic treatment - Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
14:00-14:25: Antipsychotic Polypharmacy: Is it a dirty little secret or a fashion? - Shih-Ku Lin, Taipei Medical University, Taiwan
Symposium Lecture
Where
Olympia Hall
13:00 - 14:30
Meet the Expert Session presented by Janssen: Time to act in major depressive disorders (MDD)
Speakers: Siegfried Kasper, Daniel Souery, Andreas Papadopoulos, Lucie Bartova, Andrew J. Cutler
13:00 - 13:05 Welcome & Introduction - Chair: Siegfried Kasper (Austria)
13:05 - 13:45 When to act: Optimising treatment in MDD - Daniel Souery (Belgium) and Andreas Papadopoulos (UK)
13:45 - 14:25 How to act: Are fast-acting treatments the future? - Lucie Bartova (Austria) and Andrew J. Cutler (USA)
14:25 - 14:30 Close - Chair: Siegfried Kasper (Austria)
Meet the Expert
Where
Attica Hall
14:30 - 15:30
Keynote Lecture: The future of manualized versus personalized psychiatry
By Tarek Okasha Ain Shams University, Cairo, Egypt
Chair: Shih-Ku Lin, Taipei Medical University, Taiwan and Constantin Soldatos, University of Athens, Greece
Speaker: Tarek Okasha, Ain Shams University, Cairo, Egypt
Keynote Lecture
Where
Olympia Hall
15:30 - 16:00
Coffee Break
15:35 - 15:50
Showcase Presentation by Saladax Biomedical: Antipsychotic POCT for medication adherence and blood level monitoring
Speaker: Professor David Taylor MSc PhD FFRPS FRPharmS FRCPEdin
Director of Pharmacy and Pathology; Head of Pharmaceutical Sciences Clinical Academic Group, King's Health Partners
South London and Maudsley NHS Foundation Trust
Pharmacy Department | Maudsley Hospital | Denmark Hill | London | SE5 8AZ
Where
Olympia Foyer
16:00 - 17:30
Symposium: Pharmacological augmentation in treatment resistant mental disorders
Organized by the Hellenic Psychiatric Association
Chair: Charalampos Touloumis, Psychiatric Hospital of Attica, Greece and Christos Tsopelas, Psychiatric Hospital of Attica, Greece
16:00-16:25: Add-on treatment in schizophrenia spectrum disorders by Charalampos Touloumis, Psychiatric Hospital of Attica, Greece
16:30-16:55: Add-on treatment in treatment resistant depression by Christos Tsopelas, Psychiatric Hospital of Attica, Greece and Maria Dimitraka, Psychiatric Hospital of Attica, Greece
17:00-17:25: Clinical challenges in dual diagnosis patients by Georgios Tzeferakos, Hellenic Agency Against Drugs, Greece
Symposium Lecture
Where
Olympia Hall
17:30 - 18:30
Guided Poster Session
Chairs: Elias Eriksson, University of Gothenburg, Sweden
Chair: Maurizio Fava, Massachusetts General Hospital, USA
Speaker: Pierre Blier, University of Ottawa, Canada
Keynote Lecture
Where
Olympia Hall
10:00 - 10:30
Coffee Break
10:00 - 12:00
Meet the Expert Session presented by Takeda: Discovering ADHD in Adults
Speakers:
Susan J. Young, BSc (Hons), PhD, DClinPsy, PhD, CSci, AFBPS is the Director of Psychology Services Limited and an Honorary Professor at both Reykjavic University, Iceland and Bucks New University, UK. She is President of the UK ADHD Partnership; Vice-President of the UK Adult ADHD Network; and is Trustee of The ADHD Foundation, UK
Larry J. Klassen, MD, FRCPC, BSc is a psychiatrist and Research Chair at the Eden Mental Health Centre in Winkler, Manitoba, Canada. He specialises in the treatment of adults with Mood and Anxiety Disorders, as well as ADHD, and is involved in the ongoing education of psychiatry residents and medical students.
Josep Antoni Ramos-Quiroga, MD, PhD is a Professor of Psychiatry at Universitat Autònoma de Barcelona, Spain and is Head of the Department of Psychiatry at Hospital Universitari Vall d’Hebron, Spain.
Meet the Expert
Where
Templar's Hall
10:30 - 12:00
Symposium: Future directions to understand psychiatric diseases
Chair: Pierre Michel Llorca, CHU Clermon-Ferrand, France and Nikos Stefanis, National and Kapodistrian University of Athens, Greece
10:30-10:55: Digital psychopharmacology - Konstantinos Pastiadis, Aristotle University of Thessaloniki, Greece
11:00-11:25: New findings from old studies: Insights into the evidence of efficacy, tolerability and acceptability of antidepressants - Georgia Salanti, Universität Bern, Switzerland
11:30-11:55: Evidence does not equal evidence - Hans-Jürgen Möller, Ludwig-Maximilians-University, Germany
Symposium Lecture
Where
Olympia Hall
10:30 - 12:00
Workshop: Depression – new treatments with psychedelics
By Erich Seifritz Psychiatrische Universitätsklinik Zürich, Switzerland
Chairs: Joseph Zohar, Sheba Medical Center, Israel and Athanasios Douzenis, National and Kapodistrian University of Athens, Greece
Speaker: Erich Seifritz, Psychiatrische Universitätsklinik Zürich, Switzerland
Workshop
Where
Attica Hall
12:00 - 13:00
Keynote Lecture: New Pharmacological Treatments for Resistant Depression
By Maurizio Fava Massachusetts General Hospital, USA
Chair: Erich Seifritz, Psychiatrische Universitätsklinik Zürich, Switzerland
Speaker: Maurizio Fava, Massachusetts General Hospital, USA
Keynote Lecture
Where
Olympia Hall
13:00 - 13:30
Closing Session
13:30 - 14:30
Lunch
Stay Up to Date!
Receive the latest information about CINP 2019 by entering your information below.